大型结直肠上皮性肿瘤内镜黏膜下剥离术后的长期结局:日本前瞻性多中心队列试验
该前瞻性多中心队列试验连续纳入1740例患者共1814个≥20 mm结直肠上皮性肿瘤,评估内镜黏膜下剥离术(ESD)后5年长期结局。5年总生存率93.6%、疾病特异性生存率99.6%、肠道保留率88.6%;治愈性切除患者无转移发生,局部复发仅8处(0.5%)。作者认为良好长期预后提示ESD可作为大型结直肠上皮性肿瘤的标准治疗。
要点
- 5年总生存率93.6%、疾病特异性生存率99.6%、肠道保留率88.6%。
- 治愈性切除患者无转移发生,非治愈性切除患者有4例转移发生。
- 分块切除与切缘阳性是局部复发的独立预测因素。
核心结论
- 良好的长期预后提示ESD可作为大型结直肠上皮性肿瘤的标准治疗。
研究设计与样本
- 2013年2月至2015年1月连续纳入1740例患者共1814个≥20 mm结直肠上皮性肿瘤行ESD的前瞻性多中心队列试验,观察期5年。
- 非治愈性切除病灶按需追加根治性手术,初始治疗后行计划性多次结肠镜密集5年随访以发现转移和/或局部复发。
主要发现
- 5年总生存率、疾病特异性生存率和肠道保留率分别为93.6%、99.6%和88.6%。
- 治愈性切除患者无转移发生,非治愈性切除患者有4例转移发生。
- Kaplan-Meier曲线显示治愈性切除患者的总生存率和疾病特异性生存率均显著高于非治愈性切除患者(P > .001和P = .009)。
- 局部复发仅8处(0.5%),均经后续内镜治疗成功切除。
- 多因素logistic回归显示分块切除(风险比8.19;95%CI 1.47-45.7;P = .02)和切缘阳性(风险比8.06;95%CI 1.76-37.0;P = .007)是结直肠ESD后局部复发的显著独立预测因素。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: To determine the long-term outcomes after colorectal endoscopic submucosal dissection (ESD), we conducted a large, multicenter, prospective cohort trial with a 5-year observation period. METHODS: Between February 2013 and January 2015, we consecutively enrolled 1740 patients with 1814 colorectal epithelial neoplasms ≥20 mm who underwent ESD. Patients with noncurative resection (non-CR) lesions underwent additional radical surgery, as needed. After the initial treatment, intensive 5-year follow-up with planned multiple colonoscopies was conducted to identify metastatic and/or local recurrences. Primary outcomes were overall survival, disease-specific survival, and intestinal preservation rates. The rates of local recurrence and metachronous invasive cancer were evaluated as the secondary outcomes. RESULTS: The 5-year overall survival, disease-specific survival, and intestinal preservation rates were 93.6%, 99.6%, and 88.6%, respectively. Patients with CR lesions had no metastatic occurrence, and patients with non-CR lesions had 4 metastatic occurrences. Kaplan-Meier curves revealed that overall survival and disease-specific survival rates were significantly higher in patients with CR lesions than in those with non-CR lesions (P > .001 and P = .009, respectively). Local recurrence occurred in only 8 lesions (0.5%), which were successfully resected by subsequent endoscopic treatment. Multiple logistic regression analyses revealed that piecemeal resection (hazard ratio, 8.19; 95% CI, 1.47-45.7; P = .02) and margin-positive resection (hazard ratio, 8.06; 95% CI, 1.76-37.0; P = .007) were significant independent predictors of local recurrence after colorectal ESD. Fifteen metachronous invasive cancers (1.0%) were identified during surveillance colonoscopy, most of which required surgical resection. CONCLUSIONS: A favorable long-term prognosis indicates that ESD can be the standard treatment for large colorectal epithelial neoplasms. CLINICAL TRIAL REGISTRATION NUMBER: UMIN000010136.
引用
- Ohata K, Kobayashi N, Sakai E, et al. Long-term Outcomes After Endoscopic Submucosal Dissection for Large Colorectal Epithelial Neoplasms: A Prospective, Multicenter, Cohort Trial From Japan. Gastroenterology. 2022. PMID: 35810779. doi:10.1053/j.gastro.2022.07.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。